How to Get Keytruda (Pembrolizumab) Approved by UnitedHealthcare in Pennsylvania: Complete Timeline and Appeals Guide
Quick Answer: Getting Keytruda Covered by UnitedHealthcare in Pennsylvania
UnitedHealthcare requires prior authorization for Keytruda (pembrolizumab) in Pennsylvania, typically taking 5-14 business days for standard review. You'll need biomarker testing (PD-L1, MSI-H, or TMB-H), complete staging documentation, and evidence of medical necessity aligned with NCCN guidelines. If denied,